Converted by EDGARwiz

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

____________________________________________________________

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

___________________________________________________________________

 

Date of Report (Date of earliest event reported):  February 29, 2012 


UNITED HEALTH PRODUCTS, INC.

 

(Exact name of registrant as specified in its charter)

 

 

 

 

Nevada

814-00717

84-1517723

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

 

 

4400 Route 9 South, Suite 1000

Freehold, NJ

07728

 

(Address of Principal Executive Offices)

(Zip Code)

 

 

 

 

Registrant’s telephone number, including area code: (646) 961-4459

 

 

 

 

N/A

 

(Former name or former address, if changed since last report)

 




 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



 



-1-


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On February 29, 2012, Rodney P. Leibowitz, D.D.S., resigned as a member of our Board of Directors because he could not devote sufficient time to his responsibilities to us.


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 


Date: March 2, 2012

UNITED HEALTH PRODUCTS, INC.

 


By:

 /s/ Dr. Phillip Forman

 




Dr. Phillip Forman




Chief Executive Officer and President






2